Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pivot Signs Service Agreement with SoluBest | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Pivot Signs Service Agreement with SoluBest

To develop Pivot’s topical bio-cannabis pipeline of products

By: Betsy Louda

, Contract Pharma

Pivot Pharmaceuticals and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions signed a Service Agreement with SoluBest. SoluBest has been selected to develop Pivot’s topical bio-cannabis pipeline of products.

 

Pivot also announced that pursuant to its previous Binding Letter of Intent to acquire Thrudermic LLC, Dr. Joseph Borovsky and Dr. Leonid Lurya have agreed to lead the development of Pivot’s topical bio-cannabis programs at SoluBest. These programs include BiPhasix semi-solid topical cream and Thrudermic transdermal nanotechnology for the delivery of cannabis through the skin barrier.

 

Dr. Patrick Frankham, Pivot Pharmaceuticals’ chief executive officer, said, “We are delighted to be moving ahead with our plan to develop best-in-class topical bio-cannabis products led by Dr. Borovsky and Dr. Lurya from Thrudermic.  We are equally happy to report that we have found a very qualified laboratory and development partner for our topical development programs for our BiPhasix and Thrudermic technologies in Israel.  This announcement accelerates our product development and confirms that we will be ready to introduce several bio-cannabis based products to the market in 2018.  The potential to recognize revenue from quality products will help patients and caregivers better manage their health conditions.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics